Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2010
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097115A1 Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol
09/02/2010WO2010097114A1 Novel combination of therapeutic agents
09/02/2010WO2010048384A3 Arformoterol and tiotropium compositions and methods for use
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222427 Pharmaceutical composition comprising oseltamivir phosphate
09/02/2010US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100222393 Muscarinic receptor antagonists
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222349 Quinoline derivatives used to treat inflammatory and allergic diseases
09/02/2010US20100222336 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication
09/02/2010US20100222324 Substituted Indole Compounds
09/02/2010US20100222314 Aqueous-based Pharmaceutical Composition
09/02/2010US20100222312 Delayed-release glucocorticoid treatment of asthma
09/02/2010US20100222311 Solid formulations of crystalline compounds
09/02/2010US20100222300 A2B Adenosine Receptor Antagonists
09/02/2010US20100222294 Formulations of ATP and Analogs of ATP
09/02/2010US20100222278 Use of leptin for the prevention of excess body weight and composition containing leptin
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222270 Heterocyclic compounds as crth2 receptor antagonists
09/02/2010US20100222257 Substituted phenethylamines
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221371 Sophorae radix extract for prevention and treatment of respiratory diseases
09/02/2010US20100221357 Drug delivery product and methods
09/02/2010US20100221343 Compositions and methods of making brittle-matrix particles through blister pack freezing
09/02/2010US20100221342 Composition and method of treating a sore throat
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221298 Novel galenical system for active transport, method for preparation and use
09/02/2010US20100221279 Kennel cough vaccine
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221210 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/02/2010US20100221208 Treatment and Diagnostic Methods for Fibrosis Related Disorders
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010CA2790906A1 Composition and methods for clotting blood
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753337A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010CA2752981A1 Indole derivatives as crth2 receptor antagonists
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2222649A2 Novel crystalline forms
09/01/2010EP2222648A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
09/01/2010EP2222637A1 Amidine-containing compounds useful as muscarinic receptor antagonists
09/01/2010EP2222272A1 Respiratory disease treatment
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP1983987B1 Dihydrodiazepines useful as inhibitors of protein kinases
09/01/2010EP1720546B1 Novel, sustained-action beta-2-agonists and their use as medicaments
09/01/2010EP1558614B1 Pyridopyrrolizine and pyridoindolizine derivatives
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010CN101821392A RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
09/01/2010CN101817800A Novel medicaments for the treatment of chronic obstructive pulmonary diseases
09/01/2010CN101816795A Nanometer magnetic control throat anesthesia compound preparation and use thereof
09/01/2010CN101816782A Composite enzyme apophlegmatisant
09/01/2010CN101816772A Chinese medicament for treating globus hystericuss and preparation method thereof
09/01/2010CN101816763A Chinese medicament for treating chronic pharyngitis and preparation method thereof
09/01/2010CN101816757A Chinese medicinal composition for treating antiaditis and preparation method thereof
09/01/2010CN101816753A Method for detecting quality of compound preparation for treating cold
09/01/2010CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound
09/01/2010CN101816736A Chinese medicament capsule for curing nasosinusitis
09/01/2010CN101816734A Medicament for treating chronic pharyngitis
09/01/2010CN101816706A Chinese traditional medicament valid target composition for treating viral respiratory infection diseases
09/01/2010CN101816688A Chinese medicinal composition for treating anemopyretic cold and preparation method thereof
09/01/2010CN101816681A Quality detection method of infant paracetamol and amantadine hydrochloride particles
09/01/2010CN101816672A Composition containing roxithromycin and ambroxol and preparation method thereof
09/01/2010CN101816670A New medical application of beta-sodium aescinate
09/01/2010CN101816668A Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone
09/01/2010CN101816654A Medicinal combination of nalmefene hydrochloride and polyvinyl pyrrolidone and preparation method thereof
09/01/2010CN101816313A Chinese medicinal camphor ball
09/01/2010CN101301291B Compound enrofloxacin injection for animals and preparation thereof
09/01/2010CN101229319B Cold cough oral liquid
09/01/2010CN101199572B Medicament of expectorant anti-asthma, preparing method and function thereof
09/01/2010CN101168032B Medicine for treating asthma
09/01/2010CN101023996B Chinese medicine for treating exogenous epidemic disease and anemopyretic cold
08/2010
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786110 Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists
08/31/2010US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
08/31/2010US7785870 Cell-specific expression/replication vector
08/31/2010US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases
08/31/2010US7785791 Polypeptide variants with altered effector function
08/31/2010US7785775 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2567981C Constrained himbacine analogs as thrombin receptor antagonists
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/31/2010CA2389545C Chemokine receptor binding heterocyclic compounds
08/26/2010WO2010095714A1 Novel compounds and binding inhibitors, anti-allergic agents, anti-asthmatic agents and anti-inflammatory agents
08/26/2010WO2010095706A1 Novel anti-inflammatory compounds
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095227A1 Novel compound, and binding inhibitor, anti-allergic agent, anti-asthma agent and anti-inflammatory agent
08/26/2010WO2010094996A1 Oral pharmaceutical composition for use in respiratory diseases
08/26/2010WO2010094964A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
08/26/2010WO2010094956A1 Triazolopyridine derivatives as p38 map kinase inhibitors
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 878